Merck in a statement said it is "continuously innovating to enhance the benefits of Keytruda in order to reach greater numbers of patients and to increase efficacy and convenience of the treatment."NewYork Feb23
a current prediction, page-117
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.015(3.85%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 41.0¢ | 39.5¢ | $1.694M | 4.167M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 71811 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 52667 | 3 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |